Starlight Cardiovascular is a preclinical-stage medical technology company. It develops an assortment of medical devices to treat pediatric congenital heart defects (CHDs). Its product, a Ductus Arteriosus Stent, replaces a life-saving open chest surgery with a less invasive microcatheter-based procedure performed through a small incision in the skin.